All posts related to "rheumatoid arthritis"

Common Drug Review recommendation for tofacitinib (Xeljanz®)

Approved stampCommon Drug Review recommendation for tofacitinib (Xeljanz®)

Good news for Canadians living with rheumatoid arthritis

On April 21, 2015, the Common Drug Review concluded its review of tofacitinib (Xeljanz®) and recommended to public formularies that it be listed for reimbursement in combination with methotrexate (MTX), for reducing the signs and symptoms of rheumatoid arthritis (RA) in adult patients with moderately to severely active RA or as a monotherapy in those who were intolerant to MTX. Click here to read the complete Common Drug Review recommendations. Continue reading

Exercise to protect against rheumatoid arthritis

Heart Shaped Bike RackResearchers from the Karolinska Institutet in Stockholm say that exercise and physical activity may protect against the development of rheumatoid arthritis in women. The researchers studied 30,112 women enrolled in the Swedish Mammography Cohort who responded to a questionnaire in 1997 regarding physical activity. Participants were asked questions that assess daily energy use at home and wok and during leisure time. Researchers calculated the metabolic equivalent score based on duration, intensity and inactivity.

According to the research findings, 201 out of 30,112 women developed rheumatoid arthritis (RA) during the average follow-up time of 7.5 years, totalling 226, 477 person-years. Other findings include:

  • The women who developed RA expended less energy per week;
  • Women who spent more hours performing home or household chore had a 35% decreased risk of developing RA;
  • Women who spent 2 hours or more per week exercising had a 20% decreased; and,
  • Women who were inactive during their leisure time had a 27% increased risk for developing RA.

Continue reading

Morning pain: Measuring the true impact of RA

StretchAccording to recent study, there was a strong connection between the severity and intensity of morning symptoms (including pain and stiffness) and measures of disease activity in the lives of those living with rheumatoid arthritis (RA). Below are the findings from the study:

  • Relation between the severity of morning stiffness and intensity of morning pain and measures of disease activity = Pearson correlation of 0.91 (P<0.001)
  • Relation between the duration and severity of morning stiffness and the Disease Activity Score at 28 joints (DAS28) and the American College of Rheumatology -20 score (ACR20) = Pearson correlation of 0.50 (P<0.001)
  • Duration of morning stiffness and intensity of morning pain – Pearson correlation of 0.46 (P<0.001)
  • Pain on waking as measured in patient diaries and at a clinic visits as part of the ACR assessment – Pearson correlation of 0.69 (P<0.0001)

Continue reading

CRA Interview Series 2015 – Dr. Glen Hazlewood: Treatment preference

Canadian Rheumatology Association (CRA) and Allied Health Professions Association (AHPA) Interview Series 2015

Today’s feature interview – Dr. Glen Hazlewood: Treatment preference of patients with early rheumatoid arthritis

ABN reporters from Canada’s arthritis consumer organizations interviewed leading health professionals and researchers during last month’s CRA and AHPA annual meetings.

Beginning March 9, feature interviews will be posted on the ABN YouTube channel http://bit.ly/ABNYouTube. Please help us raise awareness about the important work going on in Canada by sharing the interviews with your organizational and social networks.

About Dr. Glen Hazlewood (from Arthritis Research Canada)

Picture of Glen HazlewoodDr. Glen Hazlewood is a practicing rheumatologist in Calgary and is currently working towards his PhD in Clinical Epidemiology through the Institute of Health, Policy, Management and Evaluation, University of Toronto. His PhD co-supervisors are Dr. Deborah Marshall and Dr. Claire Bombardier. Continue reading

CRA Interview Series 2015 – Dr. Hani El-Gabalawy: Preventing rheumatoid arthritis

Canadian Rheumatology Association (CRA) and Allied Health Professions Association (AHPA) Interview Series 2015

Today’s feature interview – Dr. Hani El-Gabalawy: Preventing rheumatoid arthritis. What we’ll need to know before we start navigating uncharted territory.

ABN reporters from Canada’s arthritis consumer organizations interviewed leading health professionals and researchers during last month’s CRA and AHPA annual meetings.

Beginning March 9, feature interviews will be posted on the ABN YouTube channel http://bit.ly/ABNYouTube. Please help us raise awareness about the important work going on in Canada by sharing the interviews with your organizational and social networks.

About Dr. Hani El-Gabalawy

Picture of Dr. El-Gabalawy

Photo from IMHA

Dr. El-Gabalawy is an internationally recognized rheumatologist and Professor of Medicine and Immunology and senior clinician scientist at the University of Manitoba. He is also the Endowed Rheumatology Research Chair at the university and Scientific Director of the Institute of Musculoskeletal Health and Arthritis.  Continue reading

CRA Interview Series 2015 – Dr. Diane Lacaille: Rheumatologist care in rheumatoid arthritis

Arthritis Broadcast Network’s “CRA Interview Series 2015″ – Dr. Diane Lacaille:  Rheumatologist care in rheumatoid arthritis

Today’s feature interview – Dr. Diane Lacaille

ABN reporters from Canada’s arthritis consumer organizations interviewed leading health professionals and researchers during last month’s CRA and AHPA annual meetings.

Beginning, March 9, feature interviews will be posted on the ABN YouTube channel http://bit.ly/ABNYouTube. Please help us raise awareness about the important work going on in Canada by sharing the interviews with your organizational and social networks.

Note answers in this interview are provided in French only. A translation will be provided in the next few weeks.

About Dr. Diane Lacaille

 

Picture of DianeSenior Research Scientist, Rheumatology
Mary Pack Chair in Rheumatology

MD, MHSc, FRCPC

Appointments
Professor, Division of Rheumatology
Department of Medicine
University of British Columbia

Diane Lacaille is a Professor in the Division of Rheumatology at the University of British Columbia, and a Senior Research Scientist at Arthritis Research Canada, in Vancouver. She practices rheumatology at the Mary Pack Arthritis Centre and she has a hospital appointment at Vancouver Hospital Health Sciences Centre (VHHSC). She completed medical school and internal medicine training at McGill University in Montreal, and her Rheumatology training and a Master’s in Health Sciences, clinical epidemiology track, at the University of British Columbia.

Her research focuses on two areas: 1) Studying the impact of arthritis on employment and preventing work disability, and 2) Evaluating the quality of health care services received by people with RA, using a population-based cohort of RA for the province of BC.

About rheumatoid arthritis

Rheumatoid arthritis is an autoimmune disease with hallmark symptoms of inflammation and resulting pain. It is a disease process (like cancer or diabetes) where the body’s immune system mistakenly attacks its own healthy joints. It is a relatively common disease-approximately 300,000 or 1 in 100 Canadians get it-and is often devastating to a person’s body if not treated properly. The disease process causes swelling and pain in and around joints and can affect the body’s organs, including the eyes, lungs, and heart. Rheumatoid arthritis most commonly affects the hands and feet. Other joints often affected include the elbows, shoulders, neck, jaw, ankles, knees, and hips. When moderate to severe, the disease reduces a person’s life span by as much as a dozen years.